Kuhns Lisa M, Mimiaga Matthew J, Reisner Sari L, Biello Katie, Garofalo Robert
Division of Adolescent Medicine, Ann & Robert H. Lurie Children's Hospital, 225 E. Chicago Avenue, Box 161, Chicago, IL, 60611, USA.
Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
BMC Public Health. 2017 Sep 16;17(1):713. doi: 10.1186/s12889-017-4734-5.
BACKGROUND: Transgender women in the U.S. have an alarmingly high incidence rate of HIV infection; condomless anal and vaginal sex is the primary risk behavior driving transmission. Young transgender women are the subpopulation at the highest risk for HIV. Despite this, there are no published randomized controlled efficacy trials testing interventions to reduce sexual risk for HIV among this group. This paper describes the design of a group-based intervention trial to reduce sexual risk for HIV acquisition and transmission in young transgender women. METHODS: This study, funded by the National Institutes of Health, is a randomized controlled trial of a culturally-specific, empowerment-based, and group-delivered six-session HIV prevention intervention, Project LifeSkills, among sexually active young transgender women, ages 16-29 years in Boston and Chicago. Participants are randomized (2:2:1) to either the LifeSkills intervention, standard of care only, or a diet and nutrition time- and attention-matched control. At enrollment, all participants receive standardized HIV pre- and post-test counseling and screening for HIV and urogenital gonorrhea and chlamydia infections. The primary outcome is difference in the rate of change in the number of self-reported condomless anal or vaginal sex acts during the prior 4-months, assessed at baseline, 4-, 8-, and 12-month follow-up visits. DISCUSSION: Behavioral interventions to reduce sexual risk for HIV acquisition and transmission are sorely needed for young transgender women. This study will provide evidence to determine feasibility and efficacy in one of the first rigorously designed trials for this population. TRIAL REGISTRATION: ClinicalTrials.gov number, NCT01575938 , registered March 29, 2012.
背景:美国的跨性别女性感染艾滋病毒的发病率高得惊人;无保护的肛交和阴道性交是导致传播的主要风险行为。年轻的跨性别女性是感染艾滋病毒风险最高的亚群体。尽管如此,尚无已发表的随机对照疗效试验来测试降低该群体艾滋病毒性风险的干预措施。本文描述了一项基于小组的干预试验的设计,该试验旨在降低年轻跨性别女性感染和传播艾滋病毒的性风险。 方法:本研究由美国国立卫生研究院资助,是一项针对波士顿和芝加哥年龄在16 - 29岁、有性活动的年轻跨性别女性进行的随机对照试验,试验内容为一项针对特定文化、基于赋权且通过小组实施的为期六节的艾滋病毒预防干预措施——“生活技能项目”。参与者被随机分配(2:2:1)至“生活技能”干预组、仅接受标准护理组或饮食与营养时间及关注度匹配的对照组。在入组时,所有参与者均接受标准化的艾滋病毒检测前和检测后咨询,并接受艾滋病毒以及泌尿生殖系统淋病和衣原体感染的筛查。主要结局是在基线、4个月、8个月和12个月随访时评估的前4个月内自我报告的无保护肛交或阴道性行为次数的变化率差异。 讨论:年轻跨性别女性迫切需要降低感染和传播艾滋病毒性风险的行为干预措施。本研究将为确定针对该人群的首批严格设计试验之一的可行性和疗效提供证据。 试验注册:ClinicalTrials.gov编号,NCT01575938,于2012年3月29日注册。
J Acquir Immune Defic Syndr. 2016-8-15
J Acquir Immune Defic Syndr. 2015-3-1
Lancet Infect Dis. 2012-12-21